Skip to content
  • Friday, 14 August 2026
  • 11:56 pm
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • Researchers at ETH Zurich and EPFL Unveil PLATON A Radical New Approach to 3D Particle Tracking and Medical Imaging
Advanced Materials Science

Researchers at ETH Zurich and EPFL Unveil PLATON A Radical New Approach to 3D Particle Tracking and Medical Imaging

Nila Kartika Wati Jul 24, 2026 0

The pursuit of the fundamental building blocks of the universe has long been a game of scale, where larger detectors…

Read More
Pharmaceutical R&D

The FDA’s Pursuit of "Radical Transparency" Sparks Debate on Policy Clarity

Teuku Ryan Jun 29, 2026 0

The U.S. Food and Drug Administration’s (FDA) ambitious drive towards "radical transparency," particularly through the public release of Complete Response…

Read More
Laboratory Automation & Robotics

BioNTech’s Meteoric Rise from Pandemic Savior to Oncology Powerhouse Undergoes Radical Restructuring and Job Cuts

Lana Keisha Jun 19, 2026 0

Mainz, Germany — BioNTech SE, the German biotechnology firm that achieved global recognition for its pivotal role in developing the…

Read More
Unraveling Nature’s Proton Highway: Researchers Pinpoint Crucial Molecular Structure in Charge TransportUnlocking the Secrets of Bacterial Reproduction: UAB Scientists Reveal Molecular Mechanism Governing Cell DivisionIn Focus Wrapped: Metabolite monitoring in cell cultureThe biotech bi-weekly: partnerships facilitating antibody discovery and AI drug development
MEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthJapan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactLLMOps in 2026: The 10 Tools Every Team Must HaveThe Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals Plummet
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’sKing’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid DecompositionSanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
YOU MAY HAVE MISSED
Laboratory Automation & Robotics
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’s
Lana Keisha Jul 25, 2026
Neuroscience & Brain Research
King’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286
Rifan Muazin Jul 25, 2026
Advanced Materials Science
Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid Decomposition
Nila Kartika Wati Jul 25, 2026
Pharmaceutical R&D
Sanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
Teuku Ryan Jul 25, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ